athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $132.97, for a total transaction of $106,376.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Brandon H. Hull also recently made the following trade(s):
- On Monday, November 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00.
- On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00.
athenahealth, Inc. (NASDAQ:ATHN) opened at $133.85 on Wednesday. athenahealth, Inc. has a one year low of $90.11 and a one year high of $158.66. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. The firm has a market cap of $5,382.78, a P/E ratio of 113.99, a PEG ratio of 5.05 and a beta of 1.57.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same quarter in the prior year, the business earned $0.60 EPS. The business’s quarterly revenue was up 10.1% on a year-over-year basis. research analysts expect that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.
Several large investors have recently modified their holdings of ATHN. Turner Investments LLC bought a new position in shares of athenahealth in the 2nd quarter worth approximately $105,000. Bessemer Group Inc. lifted its stake in shares of athenahealth by 13.7% in the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of athenahealth by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares during the period. Seven Bridges Advisors LLC lifted its stake in shares of athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after purchasing an additional 67 shares during the period. Finally, BNP Paribas Arbitrage SA lifted its stake in shares of athenahealth by 123.8% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares during the period.
A number of brokerages recently issued reports on ATHN. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday. Cantor Fitzgerald reiterated a “hold” rating and issued a $120.00 price target on shares of athenahealth in a research note on Friday, October 27th. SunTrust Banks restated a “buy” rating and set a $156.00 target price on shares of athenahealth in a research note on Wednesday, October 25th. Leerink Swann lowered their target price on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating on the stock in a research note on Monday, October 23rd. Finally, Wells Fargo & Company lowered their target price on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research note on Monday, October 23rd. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have assigned a buy rating to the company’s stock. athenahealth currently has an average rating of “Hold” and a consensus target price of $143.22.
ILLEGAL ACTIVITY NOTICE: “Brandon H. Hull Sells 800 Shares of athenahealth, Inc. (ATHN) Stock” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://ledgergazette.com/2017/12/06/brandon-h-hull-sells-800-shares-of-athenahealth-inc-athn-stock.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.